Skye Bioscience (SKYE) has released an update to notify the public and investors about a regulation fd disclosure.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
On January 29, 2024, the Company issued a press release regarding a Private Placement and provided it as part of a Current Report. The information contained within, including an attached presentation, is for informational purposes and is not considered legally filed under the Securities Exchange Act nor is it to be included in the Company’s filings under the Securities Act.
For further insights into SKYE stock, check out TipRanks’ Stock Analysis page.